Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle

Inflammatory Bowel Diseases

Volumn 5, Issue 1, 1999, Pages 16-23

  Eliakim, Rami ^a   Karmeli, Fanny ^a   Cohen, Patrizia ^a   Rachmilewitz, Danny ^a   Shao, Jin S ^b   Alpers, David H ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colitis; Iodoacetamide; Jejunitis; Surfactant

Indexed keywords

ANTIBODY; IODOACETAMIDE; NITRIC OXIDE; SURFACTANT; THIOL REAGENT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COLITIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; ENTERITIS; INTESTINE MUCOSA; INTRAVENOUS DRUG ADMINISTRATION; JEJUNUM DISEASE; MALE; METABOLISM; PARTICLE SIZE; PATHOLOGY; RAT; REFERENCE VALUE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES; COLITIS; DISEASE MODELS, ANIMAL; ENTERITIS; INJECTIONS, INTRAVENOUS; INTESTINAL MUCOSA; IODOACETAMIDE; JEJUNAL DISEASES; MALE; NITRIC OXIDE; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SULFHYDRYL REAGENTS; SURFACE-ACTIVE AGENTS;

EID: 0033070299     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199902000-00003     Document Type: Article

References (27)

1. Butler BD, Lichtenberger LM, Hills BA. Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate. Am J Physiol 1983;244:G645-51.
2. Anderson JT, Munay FE, Gollacher C, Ross OE, Milne G, Hopwood D. Novel surfactant-like lipid (SLL) of human stomach, duodenum and rectum. Gut 1993;34:S16.
3. DeSchryver-Kecskemeti K, Eliakim R, Carroll S, Stenson WF, Moxley MA, Alpers DH. Intestinal surfactant-like material: a novel secretory product of the rat enterocyte. J Clin Invest 1990; 84:1355-61.
4. Tietze CC, Becich MJ, Engle M, Stenson WF, Eliakim R, Alpers DH. CaCo-2 cell transfection by rat intestinal alkaline phosphatase cDNA increases surfactant-like particles. Am J Physiol 1992;263: G756-66.
5. Eliakim R, Goetz GS, Rubio S, et al. Isolation and characterization of surfactant-like particles in rat and human colon. Am J Physiol 1997;272:G425-34.
6. Magnusson KE. Physicochemical properties of bacterial surfaces. Biochem Soc Trans 1989;17:454-8.
7. Mauch F, Bode G, Ditschuneit H, Malfertheiner P. Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori. Gastroenterology 1993;105:1698-704.
8. Hills BA. Gastric mucosal barrier: evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it. Gut 1993;34:588-93.
9. Goetz GS, Mahmood A, Huttgren SJ, et al. Intestinal surfactant-like particles contain adhesin receptors for human uropathogenic E. coli. Gastroenterology 1995;108:A824.
10. Lichtenberger LM. Membranes and barriers: with a focus on the gastric mucosal barrier. Clin Invest Med 1987;10:181-8.
11. Mack DR, Neumann AW, Palicova Z, Sherman DM. Hydrophobicity of the intestinal tract. Am J Physiol 1992;262:G171-7.
12. Scheurlen C, Materna T, Loosemann B, Breuer T, Malfertheinen P, Sauerbruch T. Altered luminal surface hydrophobicity of noninflamed mucosa in patients with Crohn's disease. Gastroenterology 1995;108:A912.
13. Lugea A, Guarner F, Domingo A, Salas A, Malagelada J-R. The colonic surfactant as a key defensive barrier against macromol-ecules and toxins. Gastroenterology 1997;112:A3105.
14. Fabia R, AiRajab A, Willen R, et al. Effects of phosphatidylcholine and phosphatidylinositol on acetic acid-induced colitis in rats. Digestion 1992;53:35-44.
15. Mourelle M, Guarner F, Malagelada JR. Polyunsaturated phosphatidylcholine prevents structure formation in a rat model of colitis. Gastroenterology 1996;110:1093-7.
16. Rachmilewitz D, Karmeli F, Okon E. Sulphydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. Gastroenterology 1995;109:98-106.
17. Mahmood A, Mahmood S, DeSchryver-Kecskemati K, Alpers DH. Characterization of proteins in rat and human intestinal surfactant-like particles. Arch Biochem Biophys 1993;300:280-6.
18. Bush PA, Gonzalez NE, Griscabage JH, Ignarro LJ. Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Commun 1992;185:960-6.
19. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutanenous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
20. Sharon P, Ligumsky M, Rachmilewitz D, Zor U. Role of prostaglandins in ulcerative colitis: enhanced production during active disease and inhibition by sulphasalazine. Gastroenterology 1978; 65:638-40.
21. Rachmilewitz D, Okon E, Karmeli F. Sulphydryl blocker-induced small intestinal inflammation in rats - a new model mimicking Crohn's disease. Gut 1997;41:358-65.
22. Karmeli F, Eliakim R, Okon E, Samuni A, Rachmilewitz D. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. Gut 1995;37:386-93.
23. Lichtenberger LM, Romero JJ, Kao YC, Dial EJ. Gastric protective activity of mixtures of saturated polar and neutral lipids in rats. Gastroenterology 1990;99:311-26.
24. Tatsumi Y, Lichtenberger LM. Molecular association of trinitrobenzene sulfonic acid and surface antibodies in the development of colitis in rats. Gastroenterology 1996;110:780-9.
25. Strayer DS, Herting E, Sun B, Robertson B. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. Am J Respir Care Med 1996;153: 1116-22.
26. Garcia-Lafuente A, Antolin M, Guarner F, et al. Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 1997;272:G10-5.
27. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bactericides species, mediate chronic colitis, gastritis, and arthritis, in HLA-B27/human beta-2 microglobulin transgenic rats. J Clin Invest 1996;98:945-53.